Publications by authors named "M Krailo"

Claim this Profile
O
Outcome of Children With Intermediate-Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group.
Adriana Fonseca, Doojduen Villaluna, Mark Krailo, Thomas A Olson, Farzana Pashankar

Pediatr Blood Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han, Mark D Krailo

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children's Oncology Group.
Safia K Ahmed, Odion Binitie, Mark Krailo, Daniel J Indelicato, Alexandra K Callan

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent / Refractory Osteosarcoma, A Report from the Children's Oncology Group (COG).
Katherine A Janeway, Alexander J Chou, Allen Buxton, Joel Reid, Michael S Isakoff, Mark Krailo

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III Trial.
Zachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, Max R Langham, Jin Piao, Mark Krailo

Ann Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis